Alerts will be sent to your verified email
Verify Email
MOREPENLAB
|
Morepen Laboratories
|
Blue Jet Healthcare
|
IOL Chem & Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
API Sector
|
|||
|
Global DMFs filed
|
211.0 . | n/a | n/a |
|
Pharmaceutical Sector
|
|||
|
R&D as a % of Total Sales
|
0.87 % | n/a | 0.97 % |
|
Financials
|
|||
|
5 yr Average ROE
|
13.76 % | 42.73 % | 18.85 % |
|
5yr average Equity Multiplier
|
2.02 | 1.73 | 1.4 |
|
5yr Average Asset Turnover Ratio
|
1.33 | 0.92 | 1.09 |
|
5yr Avg Net Profit Margin
|
5.03 % | 25.85 % | 12.19 % |
|
Price to Book
|
3.43 | 8.49 | 1.56 |
|
P/E
|
30.2 | 43.82 | 18.66 |
|
5yr Avg Cash Conversion Cycle
|
32.82 Days | 116.62 Days | 55.45 Days |
|
Inventory Days
|
51.36 Days | 58.24 Days | 57.94 Days |
|
Days Receivable
|
66.16 Days | 118.17 Days | 80.26 Days |
|
Days Payable
|
105.81 Days | 86.0 Days | 83.28 Days |
|
5yr Average Interest Coverage Ratio
|
34.8 | 74.56 | 46.53 |
|
5yr Avg ROCE
|
14.99 % | 53.37 % | 24.63 % |
|
5yr Avg Operating Profit Margin
|
9.11 % | 39.22 % | 18.65 % |
|
5 yr average Debt to Equity
|
0.13 | 0.14 | 0.03 |
|
5yr CAGR Net Profit
|
6.04 % | 2.01 % | -20.73 % |
|
5yr Average Return on Assets
|
6.81 % | 23.88 % | 13.46 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
38.22 % | 86.0 % | 48.19 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
3.68 % | 0.0 | 4.5 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | -0.54 % | 0.04 % |
|
Morepen Laboratories
|
Blue Jet Healthcare
|
IOL Chem & Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|